FierceBiotech

Regeneron is racing to regulators…

news2025-09-17T09:01:00+00:00September 17th, 2025|FierceBiotech|

At this year’s meeting of the…

news2025-09-17T08:02:00+00:00September 17th, 2025|FierceBiotech|

A phase 3 trial of Priovant…

news2025-09-17T06:21:00+00:00September 17th, 2025|FierceBiotech|

Sanofi’s head of R&D, Houman…

news2025-09-17T05:45:00+00:00September 17th, 2025|FierceBiotech|

Innate Pharma is set to lose 30%…

news2025-09-17T05:17:00+00:00September 17th, 2025|FierceBiotech|

With drugmakers freezing…

news2025-09-17T05:05:00+00:00September 17th, 2025|FierceBiotech|

During his tenure at Genentech,…

news2025-09-16T13:20:00+00:00September 16th, 2025|FierceBiotech|

Politicians scrambled to arrange…

news2025-09-16T11:57:00+00:00September 16th, 2025|FierceBiotech|

Genmab has dropped an…

news2025-09-16T10:34:00+00:00September 16th, 2025|FierceBiotech|

Apollo Therapeutics’ $15 million…

news2025-09-16T08:47:00+00:00September 16th, 2025|FierceBiotech|

Previous434445Next